Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS …
A Goette, WJ Kwong, MD Ezekowitz, M Banach… - EP …, 2018 - academic.oup.com
Abstract Aims The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial
fibrillation (ENSURE-AF)(NCT02072434) study was a multicentre prospective, randomized,
open-label, blinded-endpoint evaluation (PROBE) trial comparing edoxaban with
enoxaparin/warfarin followed by warfarin alone in 2199 non-valvular atrial fibrillation
patients undergoing electrical cardioversion and showed comparable rates of bleeding and
thromboembolism between treatments. This prespecified ancillary analysis investigated the …
fibrillation (ENSURE-AF)(NCT02072434) study was a multicentre prospective, randomized,
open-label, blinded-endpoint evaluation (PROBE) trial comparing edoxaban with
enoxaparin/warfarin followed by warfarin alone in 2199 non-valvular atrial fibrillation
patients undergoing electrical cardioversion and showed comparable rates of bleeding and
thromboembolism between treatments. This prespecified ancillary analysis investigated the …
EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE …
A Goette, W Kwong, M Ezekowitz, M Banach… - Journal of the American …, 2017 - jacc.org
Background: ENSURE-AF (NCT 02072434) study, a multi-center, PROBE trial comparing
edoxaban with enoxaparin/warfarin followed by warfarin alone in 2,199 non-valvular atrial
fibrillation patients undergoing electrical cardioversion showed comparable rates of
bleeding and thromboembolism between treatments. This subanalysis investigated the
impact of therapy on treatment satisfaction and utilization of health care services. Methods:
The Perception of Anticoagulant Treatment Questionnaire (PACT-Q2) was completed by …
edoxaban with enoxaparin/warfarin followed by warfarin alone in 2,199 non-valvular atrial
fibrillation patients undergoing electrical cardioversion showed comparable rates of
bleeding and thromboembolism between treatments. This subanalysis investigated the
impact of therapy on treatment satisfaction and utilization of health care services. Methods:
The Perception of Anticoagulant Treatment Questionnaire (PACT-Q2) was completed by …
